Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-06
2007-02-06
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S029000, C549S070000, C549S072000, C546S268100, C546S280400, C514S004300
Reexamination Certificate
active
10814410
ABSTRACT:
The present invention relates to compounds of formula I,their pharmaceutically acceptable salts as well as their enantiomeric forms, diastereoisomers and racemates; the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds as inhibitors of histone deacetylase (HDAC) and therefore in the control or prevention of illnesses and disorders as mentioned above, or in the manufacture of corresponding pharmaceutical compositions.
REFERENCES:
patent: 3810910 (1974-05-01), Meyer et al.
patent: 5137918 (1992-08-01), Weiershausen et al.
patent: 6784173 (2004-08-01), Leser-Reiff et al.
patent: 6869953 (2005-03-01), Haag et al.
patent: 2 062 265 (1972-05-01), None
patent: 242 851 (1987-10-01), None
patent: 847 992 (1998-06-01), None
patent: 2 167 954 (1973-08-01), None
patent: WO 02/46129 (2002-06-01), None
patent: WO 03/011851 (2003-02-01), None
patent: WO 03/013484 (2003-02-01), None
Koyama et al., Blood, 96, pp. 1490-1495 (2000).
Rastogi et al., Indian J. chem., 21B, pp. 485-487 (1982).
Moll et al., Z. Chem., 17, pp. 132-134 (1977).
Hassan et al., Indian J. Chem., 39B, pp. 764-768 (2000).
Curtin et al., J. Med. Chem., 41, pp. 74-95 (1998).
Fertig Georg
Herting Frank
Kubbies Manfred
Limberg Anja
Reiff Ulrike
Hoffmann-La Roche Inc.
Johnston George W.
Remy Brian C.
Rocha-Tramaloni Patricia S.
Shameem Golam M. M.
LandOfFree
Oxime derivatives and their use as pharmaceutically active... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxime derivatives and their use as pharmaceutically active..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxime derivatives and their use as pharmaceutically active... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3847906